The City of El Paso’s Department of Public Health (DPH) has confirmed four measles cases within the City of El Paso, the City ...
Tyrese Haliburton of the Indiana Pacers looks on during their game against the Charlotte Hornets at Spectrum Center on ...
Ave Maria University says a measles outbreak on campus has involved 48 students who are no longer contagious and five more students recently are quarantined, according to a university advisory.
Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for ...
More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...
Medications have kept Tori Samuel’s HIV at bay for decades. The part-time worker from Ocala, Florida, has thrived, marrying her husband and giving birth to three children, none of whom have the virus.
A 20-year-old man in Taiwan went to a dermatology clinic for a strange rash that had developed across his shoulders and chest. The raised, red, and itchy condition had been bothering him for a full ...
A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...
The Pentagon has ordered the military command that processes new recruits to hold off on initial training for people who are HIV-positive and recently joined the military, CNN has learned, saying that ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Though Gilead Sciences made waves last June with a landmark FDA approval for its twice-yearly HIV preventive Yeztugo (lenacapavir), the first-in-class drug had previously been used as a long-acting ...
Advancements in HIV/AIDS research, drug development, and clinical practice since the 1980s have made it possible for people living with HIV to lead long, productive lives and keep the virus in check ...
The Trump administration's funding cuts to PEPFAR and USAID disrupted global HIV treatment and prevention, threatening progress made over decades. Lenacapavir's FDA approval as a long-acting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results